Med Lasers 2023; 12(3): 147-152  https://doi.org/10.25289/ML.23.034
Review of high-intensity focused ultrasound for lipolysis: clinical and preclinical studies
Young Gue Koh1, Ka Ram Kim1, Yoon Hwan Lee1, Hye Sung Han2, Kwang Ho Yoo2
1Department of Dermatology, Chung-Ang University Hospital, Seoul, Republic of Korea
2Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea
Correspondence to: Kwang Ho Yoo
E-mail: psyfan9077@naver.com
ORCID: https://orcid.org/0000-0002-0137-6849
Received: September 15, 2023; Accepted: September 18, 2023; Published online: September 19, 2023.
© Korean Society for Laser Medicine and Surgery. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
High-intensity focused ultrasound (HIFU) is an increasingly popular treatment modality that is used for non-invasive body contouring. Several clinical studies have reported a significant reduction in subcutaneous adipose tissue after HIFU treatment, along with the histologic degradation of adipocytes and fat membranes. Similarly, preclinical studies have confirmed the safety and efficacy of HIFU and identified two mechanisms, namely heat-induced apoptosis and acoustic cavitation. Although the lipolytic effects of HIFU are well documented, insufficient research has been done on the metabolic changes caused by HIFU lipolysis yet. A recent meta-analysis of the outcome of non-invasive fat removal suggests that HIFU may positively lead to weight loss and wasit circumference reduction in the serum lipid profiles, potentially expanding its use from aesthetic to metabolic treatments. In conclusion, HIFU is emerging as an effective and safe tool for fat reduction via heat-induced apoptosis and acoustic cavitation and its use is expected to increase in body contouring. As more data emerges on its metabolic effects, HIFU may also find a place as adjunctive therapy for metabolic disorders.
Keywords: Body contouring; High-intensity focused ultrasound; Lipolysis
INTRODUCTION

The removal of unwanted fat for body contouring has a long history. In 1921, the French surgeon Charles Dujarier performed a lipectomy using a uterine curette to remove fat from both the knees and calves of a ballerina but damaged the femoral artery and had to amputate a leg. Since then, new liposuction techniques have been developed and refined; however, these techniques are still invasive and have been reported to have some side effects such as hematoma, seroma, and scarring [1,2].

Several non-invasive body sculpting techniques have been used to address existing issues, such as radiofrequency, cryolipolysis, laser, and high-intensity focused ultrasound (HIFU) [3].

Ultrasound devices have been proposed for lipolysis; however, the clinical efficacy of external devices has not been confirmed. In 2005, a non-thermal-based device, the Contour I device (UltraShape Ltd.), received CE mark approval, which showed significant improvements in circumference and skin fat thickness for 12 weeks after a single treatment on the abdomen and thighs in 2007. This was achieved by delivering acoustic energy to disrupt fat tissue without causing an increase in temperature [4,5].

HIFU can increase the temperature of a selected, isolated tissue volume to at least 55°C and maintain this temperature for at least 1 second, which is known to lead to coagulative necrosis and immediate cell death. HIFU can destroy adipose tissue through thermal stimulation as well as acoustic energy; however, due to technical problems, there have been concerns about side effects such as tissue necrosis in unwanted areas [6]. Nevertheless, HIFU lipolysis has been reported to be effective and safe for body contouring and is currently one of the most widely used techniques.

For lipolysis with HIFU, clinical studies were mainly conducted before theoretical studies. Therefore, this article will review the relevant clinical and preclinical studies accordingly.

CLINICAL STUDIES

In 2009, 282 patients underwent anterior abdominal and flank HIFU treatment with LipoSonix (Medicis Technologies Corporation) and showed a mean waist circumference reduction of 4.7 cm and the histologically confirmed collapse of adipocytes and membranes at 3 months [7].

In a 2011 study involving 152 patients treated with an investigational HIFU device, phagocytosis of fat and cell debris occurred after approximately 2 to 4 weeks, with 95% recovery within 14 weeks. The incidence of adverse events was generally higher at higher energy levels; nevertheless, sufficient improvement was observed at relatively low energy levels [8].

Robinson et al. [9] also reported no significant difference in effectiveness between low and high fluences when the total fluence was set at 150 to 180 J/cm2 and the treatment passes were divided into 3 to 6 passes per group; however, pain was greater at high fluences. There was no difference in efficacy between the grid repeat (treating each site sequentially once and repeating multiple times) and site repeat (treating all passes at one site and then treating another site) methods; thus, it seems there may be no significant difference when performing multiple passes. Lee et al. [10] showed that combining HIFU with a cooling system could reduce side effects while using a high fluence setting.

In addition, studies have consistently reported that various HIFU devices are effective for subcutaneous fat reduction in various areas, including the submental area [11-13]. The above studies are summarised in Table 1.

Table 1 . Characteristics of HIFU lipolysis clinical studies

ReferenceEquipmentSample size, n (mean age, yr)Treatment areaProtocol and parametersClinical outcomesAdverse events
Fatemi, 2009 [7]LipoSonix282 (41.3)Anterior abdomen and flanksMean energy dose 137 J/cm2 divided in 2 passes, 2 different focal depthsCBWC decreased by an average of 4.7 cm after 1 treatment after 3 monthsTemporary adverse events reported in 38 (13.5%) patients: pain during treatment, prolonged tenderness, edema, hard lumps, ecchymosis
Gadsden et al., 2011 [8]Investigational HIFU Device152 (36)Study 1: abdomen (scheduled to be removed by abdominoplasty)
Study 2 and 3: anterior abdomen
166-210 J/cm2 (single pass), 59-74 J/cm2 (two passes), or 47 J/cm2 (three passes), total HIFU energy doses of 47-331 J/cm2, 2 MHz frequency, focal depth of 1.1-1.8 cmWell-demarcated disruption of adipocytes within the targeted SAT in histopathology
Phagocytosis occurred after 14-28 days and healing process was 95% complete after eight to 14 weeks
Total 703 adverse events reported: temporary treatment discomfort, edema, erythema, dysesthesia, and ecchymosis
Greater incidence in higher energy levels
No changes in clinical laboratory parameters
Robinson et al., 2014 [9]Liposonix (Model 2)118 (45.2)Abdomen, or abdomen and flanks1: 30 J/cm2, GR, 5 passes
2: 30 J/cm2, GR, 6 passes
3: 30 J/cm2, SR, 5 passes
4: 60 J/cm2, GR, 3 passes
5: 60 J/cm2, SR, 3 passes
(total fluence 150-180 J/cm2)
Primary endpoint: 2.3 ± 2.9 cm (p < 0.0001) reduction of CBWC at 12 weeks, significant differences between treatment groups
Secondary endpoint: significant CBWC reduction starting as early as 4 weeks in all groups (–1.1 ± 1.9 cm, p < 0.0001)
Pain scores were significantly higher with the 60 J/cm2 groups vs. the 30 J/cm2 treatment groups (p < 0.01)
Lee et al., 2016 [10]LIPOcel3 (33)Abdomen and flanks2 stacking passes of 95-130 J/cm21.5-5.0 cm reduction in CBWC, and postoperative fat reduction (87.89-140.99 cm3) measured by computed tomography after 4 weeksNot mentioned
Fonseca et al., 2018 [11]SonofocusTotal 31, G1: 7 (41) G2: 23 (34)AbdomenG1: 6 sessions, 3 passes, once a week
G2: 10 sessions, 2 passes, twice a week
Improvement in body contouring and reduction of the thickness of the fat layer observed by sonography in both groups in 15 days after the final treatment: G1 (p < 0.001), G2 (p < 0.0001)Only mild discomfort in treatment area
Hong et al., 2020 [12]SCIZER20 (35.80)Abdomen150 J/cm2 divided to 3 passes, 2 MHz, focal depth 13 mm, treatment was repeated at week 4 with 135 J/cm2Reduction of 3.43 cm in mean CBWC at week 8No notable clinical and laboratory findings
Kwon et al., 2021 [13]Shurink/Ultraformer40 (40.5)Submental area80 lines of 6.0 mm probe at an energy setting of 0.8-1.0 J, 60 lines of 4.5 mm probe at 0.5-0.7 J, and 3.0 mm probe at 0.3-0.5 JTreatment responders ≥ 1-point improvement in CR-SMFRS: 62.5%, satisfied patients (score ≥ 4 on the SSRS): 67.5% at post-treatment week 8Only mild and transient side effects were observed

HIFU, high-intensity focused ultrasound; CBWC, change from baseline in waist circumference; SAT, subcutaneous adipose tissue; GR, grid repeat; SR, site repeat; CR-SMFRS, 5-point Clinician-Reported Submental Fat Rating Scale; SSRS, Subject Self-Rating Scale.


PRECLINICAL STUDIES

In a study using a porcine model conducted by Jewell et al. [14], 166 to 372 J/cm2 HIFU treatment of the abdomen resulted in a transient temperature increase of up to 70°C in the focal zone after 1-2 seconds, and only a non-lethal increase was observed in the surrounding zone. In addition, gross and histopathologic examination showed that the arterioles, nerves, etc. in the treatment zone were intact. Disrupted adipocytes including lipids and cell debris were removed by macrophages, and the treated lesions healed normally. In another study with a porcine model, Lee et al. [10] observed a significant reduction in ecchymosis with simultaneous contact cooling, with lipolysis also occurring in the adipose tissue.

In HIFU, acoustic beam patterns measured with the Acoustic Intensity Measurement System (AIMS III; Onda) showed similar round to oval thermal injury zones (TIZs) formed in the elliptical zone and cadaveric skin. TIZs became larger with repeated sessions, and larger columnar TIZs were observed to form under saline infusion conditions that mimicked tumescent infiltration conditions. This may be of interest if greater effects are desired in the treatment of humans [15].

Tan et al. [16] suggested a combination therapy for the rapid removal of subcutaneous fat based on different mechanisms, which can accelerate the metabolism of HIFU-destroyed fat by supplying energy to muscles via electrical stimulation. The acoustic cavitation effect of HIFU treatment was confirmed using ex vivo porcine tissue in another study [17]. In mouse pre-adipocytes, HIFU led to the increased expression of nuclear and mitochondrial p53, apoptotic signals (BAX/BAK), and autophagy (ATG5, BECN1, and LC3II/LC3I) and the decreased expression of antiapoptotic signals (BCL2/BCL-xL) [18]. The above studies are summarised in Table 2.

Table 2 . Characteristics of HIFU lipolysis preclinical studies

ReferenceModelEquipmentSiteMain outcomes
Jewell et al., 2011 [14]Porcine (Yorkshire breed)Several different prototype devicesVentral areaHIFU (166-372 J/cm2) raised tissue temperature 70°C restricted to the focal area
Application of 68 and 86 J/cm2 did not produce clinically-significant changes in plasma lipids and liver function test
Gross examination of tissue from various organs showed no evidence of fat emboli or accumulation and histology showed well-preserved vasculature and intact nerve fibers within the HIFU treatment area
Treatment with 85.3-270 J/cm2, normal healing response included the migration of macrophages into the damaged tissue and removal of disrupted cellular debris and lipids
Lee et al., 2016 [10]PorcineLIPOcelDorsal areaLeft side was treated with contact cooling, and right side was treated without the cooling system (60-300 J/cm2)
Ecchymosis was observed on the non-cooled area immediately after HIFU treatment, but not on the cooled area
Histologically the cooled and non-cooled areas were identical, with liphophagic histiocytes observed at week 4 and lipodystrophy with resolution of inflammation at week 12
Lee et al., 2017 [15]CadaverLIPOcelAbdomen and thighHIFU acoustic beam pattern formed an ellipsoid zone at the depth of 38 mm (2 mm × 19 mm, measured by AIMS III)
HIFU treatment at a penetration depth of 13 mm generates round to oval ablative TIZs in the subcutaneous fat layer of abdomen and thigh skin
Repetitive HIFU pulses created larger and more remarkable ablative zones
Saline infusion facilitated the creation of larger oval or columnar HIFU-induced TIZs
Tan et al., 2020 [16]PorcineSelf-developed HIFU applicatorAbdomen4 Groups: sham, HIFU only, HIFU plus electrical stimulation I, and HIFU plus electrical stimulation II
Waist circumferences decreased in HIFU plus electrical stimulation I and II groups, whereas they increased for the sham and HIFU-only groups
Filippou and Damianou, 2022 [17]PorcineHIFU with custom-made concave transducerEx vivo porcine adipose tissueFormation of cavitation in porcine tissue
Byun et al., 2023 [18]Rat (Sprague-Dawley)LinearZDorsal area, mouse pre-adipocyteThe dorsal subcutaneous adipose tissue thickness in the HFD/HIFU group at was significantly lower than that of the HFD only group
Apoptotic signal and autophagy increased and anti-apoptotic signal decreased by p53 activation in mouse pre-adipocyte

HIFU, high-intensity focused ultrasound; AIMS, Acoustic Intensity Measurement System; TIZs, thermal injury zones, HFD, high fat diet.


DISCUSSION

HIFU disrupts subcutaneous adipose tissue noninvasively via heat-induced tissue necrosis and physical acoustic cavitation [17,18]. It has been reported that non-thermal focused ultrasound can also effectively remove subcutaneous fat. Although no direct comparison of the efficacy between HIFU and non-thermal focused ultrasound has been reported, future studies would likely focus on HIFU as more HIFU devices are introduced, and studies would be conducted based on the dual mechanism of HIFU.

Although the lipolytic effects of HIFU have been well reported, there is a lack of research on overall metabolic changes [19]. A meta-analysis of metabolic changes with non-surgical fat removal including HIFU conducted by Badran et al. [20] found that 2 units of body mass index, 1 kg of body weight, 5 cm of waist circumference, and 1.5 cm of abdominal fat thickness were maintained up to 60 days after treatment. Transient increases in total cholesterol, low-density lipoprotein, and triglycerides were observed after 2 weeks of treatment; however, significant differences were no longer observed thereafter. If HIFU alone can positively affect weight loss without significant changes in serum lipid profiles, it may be used as an adjunct to metabolic treatments rather than only aesthetic treatments in the future.

CONCLUSION

HIFU may be effective and safe for fat reduction through heat-induced apoptosis and acoustic cavitation. With further research on the metabolic system, it may be used not only for body contouring but also as an adjunctive treatment for metabolic disorder.

SUPPLEMENTARY MATERIALS

None.

ACKNOWLEDGMENTS

None.

AUTHOR CONTRIBUTIONS

Conceptualization: KHY. Data curation: YGK. Investigation: KRK. Methodology: YHL. Project administration: HSH. Writing–original draft: YGK. Writing–review & editing: all authors.

CONFLICT OF INTEREST

Kwang Ho Yoo is the Editor-in-Chief, Hye Sung Han is an editorial board member of the journal, but they were not involved in the review process of this manuscript. Otherwise, there is no conflict of interest to declare.

FUNDING

None.

DATA AVAILABILITY

None.

References
  1. Dolsky RL, Newman J, Fetzek JR, Anderson RW. Liposuction. History, techniques, and complications. Dermatol Clin 1987;5:313-33.
    Pubmed CrossRef
  2. Ahern RW. The history of liposuction. Semin Cutan Med Surg 2009;28:208-11.
    Pubmed CrossRef
  3. Salati SA. Non-invasive body contouring - a review: non-invasive body contouring. J Pak Assoc Dermatol 2022;32:156-67.
  4. Coleman KM, Coleman WP 3rd, Benchetrit A. Non-invasive, external ultrasonic lipolysis. Semin Cutan Med Surg 2009;28:263-7.
    Pubmed CrossRef
  5. Teitelbaum SA, Burns JL, Kubota J, Matsuda H, Otto MJ, Shirakabe Y, et al. Noninvasive body contouring by focused ultrasound: safety and efficacy of the Contour I device in a multicenter, controlled, clinical study. Plast Reconstr Surg 2007;120:779-89.
    Pubmed CrossRef
  6. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 2007;23:89-104.
    Pubmed CrossRef
  7. Fatemi A. High-intensity focused ultrasound effectively reduces adipose tissue. Semin Cutan Med Surg 2009;28:257-62.
    Pubmed CrossRef
  8. Gadsden E, Aguilar MT, Smoller BR, Jewell ML. Evaluation of a novel high-intensity focused ultrasound device for ablating subcutaneous adipose tissue for noninvasive body contouring: safety studies in human volunteers. Aesthet Surg J 2011;31:401-10.
    Pubmed CrossRef
  9. Robinson DM, Kaminer MS, Baumann L, Burns AJ, Brauer JA, Jewell M, et al. High-intensity focused ultrasound for the reduction of subcutaneous adipose tissue using multiple treatment techniques. Dermatol Surg 2014;40:641-51.
    Pubmed CrossRef
  10. Lee HJ, Lee MH, Lee SG, Yeo UC, Chang SE. Evaluation of a novel device, high-intensity focused ultrasound with a contact cooling for subcutaneous fat reduction. Lasers Surg Med 2016;48:878-86.
    Pubmed CrossRef
  11. Fonseca VM, Campos PS, Certo TF, de-Faria LT, Juliano PB, Cintra DE, et al. Efficacy and safety of noninvasive focused ultrasound for treatment of subcutaneous adiposity in healthy women. J Cosmet Laser Ther 2018;20:341-50.
    Pubmed CrossRef
  12. Hong JY, Ko EJ, Choi SY, Kwon TR, Kim JH, Kim SY, et al. Efficacy and safety of high-intensity focused ultrasound for noninvasive abdominal subcutaneous fat reduction. Dermatol Surg 2020;46:213-9.
    Pubmed CrossRef
  13. Kwon HH, Yang SH, Choi M, Jung JY, Park GH. Tightening and reduction of unwanted submental fat using triple-layer high-intensity focused ultrasound: clinical and 3-dimensional imaging analysis. Dermatol Surg 2021;47:1595-600.
    Pubmed CrossRef
  14. Jewell ML, Desilets C, Smoller BR. Evaluation of a novel high-intensity focused ultrasound device: preclinical studies in a porcine model. Aesthet Surg J 2011;31:429-34.
    Pubmed CrossRef
  15. Lee S, Kim HJ, Park HJ, Kim HM, Lee SH, Cho SB. Morphometric analysis of high-intensity focused ultrasound-induced lipolysis on cadaveric abdominal and thigh skin. Lasers Med Sci 2017;32:1143-51.
    Pubmed CrossRef
  16. Tan JS, Lin CC, Cheng JS, Chen GS. High-intensity focused ultrasound ablation combined with electrical passive exercise for fast removal of body fat. Plast Reconstr Surg 2020;145:1427-38.
    Pubmed CrossRef
  17. Filippou A, Damianou C. Experimental evaluation of high intensity focused ultrasound for fat reduction of ex vivo porcine adipose tissue. J Ultrasound 2022;25:815-25.
    Pubmed KoreaMed CrossRef
  18. Byun KA, Park HJ, Oh S, Batsukh S, Sun HJ, Kim T, et al. High-intensity focused ultrasound decreases subcutaneous fat tissue thickness by increasing apoptosis and autophagy. Biomolecules 2023;13:392.
    Pubmed KoreaMed CrossRef
  19. Kumar V, Jain A, Vadera S, Shome D, Kapoor R. Effectiveness of HIFU therapy for nonsurgical facial and body contouring: a systematic review of prospective and experimental studies. Plast Reconstr Surg 2023;151:533-44.
    Pubmed CrossRef
  20. Badran S, Doi SA, Iskeirjeh S, Aljassem G, Jafarian N, Clark J, et al. Metabolic changes after nonsurgical fat removal: a dose response meta-analysis. J Plast Reconstr Aesthet Surg 2023;77:68-77.
    Pubmed CrossRef


This Article


Cited By Articles
  • CrossRef (0)
  • Download (166)

Author ORCID Information

Services

Social Network Service

e-submission

Archives